Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

[A model of the depressive syndrome in rats induced by the neurotoxin MPTP and autoantibodies to serotonin and dopamine].

Vetrilé LA, Krupina NA, Basharova LA, Kryzhanovskiĭ GN, Evseev VA, Orlova IN, Iordanskaia TE.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1997 Jul-Aug;47(4):731-9. Russian.

PMID:
9381810
2.

[A new model of an experimental depressive syndrome in rats induced by the systemic administration to the animals of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine].

Kryzhanovskiĭ GN, Krupina NA, Kucherianu VG.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1995 Mar-Apr;45(2):377-87. Russian.

PMID:
7597834
3.

[The electrical activity of the brain structures in an experimental depressive syndrome induced by the systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to rats].

Krupina NA, Kryzhanovskiĭ GN, Iordanskaia TE, Orlova IN.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1998 Mar-Apr;48(2):313-21. Russian.

PMID:
9644812
4.

Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.

Santiago RM, Barbieiro J, Lima MM, Dombrowski PA, Andreatini R, Vital MA.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1104-14. doi: 10.1016/j.pnpbp.2010.06.004. Epub 2010 Jun 12.

PMID:
20547199
5.

[Sensorimotor reactivity (acoustic startle response) in rats with experimental depressive syndrome].

Krupina NA, Orlova IN, Kryzhanovskiĭ GN.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2001 Jan-Feb;51(1):89-97. Russian.

PMID:
11253405
6.

[The effect of parlodel on development of depressive syndrome in rats, caused by administering 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].

Krupina NA, Orlova IN, Kryzhanovskiĭ GN.

Biull Eksp Biol Med. 1995 Jul;120(7):66-70. Russian. No abstract available.

PMID:
8527787
7.

Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.

Luellen BA, Miller DB, Chisnell AC, Murphy DL, O'Callaghan JP, Andrews AM.

J Pharmacol Exp Ther. 2003 Dec;307(3):923-31. Epub 2003 Oct 15.

8.

[Dynamics of spectral parameters of the rat brain electrical activity in the model of depressive pain syndrome].

Pankova NB.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2009 Jul-Aug;59(4):495-505. Russian.

PMID:
19795813
10.

Immunization of rats with conjugates of dopamine and serotonin with bovine serum albumin prevents the development of experimental MPTP-induced depressive syndrome (electrophysiological parameters).

Pankova NB, Vetrilé LA, Basharova LA, Krupina NA, Khlebnikova NN, Rodina VI, Kryzhanovskii GN.

Neurosci Behav Physiol. 2004 Feb;34(2):131-8.

PMID:
15115320
11.

[Effects of buspirone on the development of an experimental depressive syndrome in rats, caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].

Krupina NA, Kryzhanovskiĭ GN, Orlova IN, Iordanskaia TE.

Biull Eksp Biol Med. 1996 May;121(5):489-94. Russian. No abstract available.

PMID:
8744118
12.

Activities of prolyl endopeptidase and dipeptidyl peptidase IV in brain structures of rats with dopamine deficiency-dependent MPTP-induced depressive syndrome.

Krupina NA, Zolotov NN, Bogdanova NG, Orlova IN, Khlebnikova NN, Kryzhanovskii GN.

Bull Exp Biol Med. 2006 Nov;142(5):554-6.

PMID:
17415460
13.

[A new model of depressive syndrome in rats caused by administering 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].

Kryzhanovskiĭ GN, Krupina NA, Kucherianu VG.

Biull Eksp Biol Med. 1995 Feb;119(2):125-8. Russian. No abstract available.

PMID:
7670030
14.

[Effect of parlodel on sleep-wakefulness cycle parameters in rats with experimental MPTP-induced depressive syndrome].

Iordanskaia TE, Krupina NA, Kryzhanovskiĭ GN, Orlova IN.

Biull Eksp Biol Med. 1999 Apr;127(4):380-3. Russian. No abstract available.

PMID:
10367116
15.

Experimental depressive-pain syndrome in rats with initial various anxiety-phobic levels: a behavioral study.

Krupina NA, Orlova IN, Khlebnikova NN, Grafova VN, Smirnova VS, Kukushkin ML, Kryzhanovskii GN, Pankova NB, Rodina VI.

Bull Exp Biol Med. 2002 Jun;133(6):548-52.

PMID:
12447461
16.
17.

[Effect of melipramine on the development of an experimental depressive syndrome in rats, caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].

Krupina NA, Orlova IN, Kryzhanovskiĭ GN.

Biull Eksp Biol Med. 1995 Aug;120(8):160-3. Russian. No abstract available.

PMID:
7579274
18.
19.

Effect of a prolyl endopeptidase inhibitor benzyloxycarbonyl-alanyl-proline on the development of experimental depressive syndrome in rats.

Khlebnikova NN, Krupina NA, Orlova IN, Bogdanova NG, Zolotov NN, Kryzhanovskii GN.

Bull Exp Biol Med. 2009 Mar;147(3):291-5.

PMID:
19529846
20.

The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease.

Prediger RD, Batista LC, Medeiros R, Pandolfo P, Florio JC, Takahashi RN.

Exp Neurol. 2006 Dec;202(2):391-403. Epub 2006 Aug 14.

PMID:
16908021

Supplemental Content

Support Center